Cargando…

Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer's Disease

Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by abnormal protein accumulation, synaptic dysfunction, and cognitive impairment. The continuous increase in the incidence of AD with the aged population and mortality rate indicates the urgent need for establishing n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Govindarajulu, Manoj, Pinky, Priyanka D., Bloemer, Jenna, Ghanei, Nila, Suppiramaniam, Vishnu, Amin, Rajesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215547/ https://www.ncbi.nlm.nih.gov/pubmed/30420872 http://dx.doi.org/10.1155/2018/2010675

Ejemplares similares

Selective PPAR-Delta/PPAR-Gamma Activation Improves Cognition in a Model of Alzheimer’s Disease
por: Steinke, Ian, et al.
Publicado: (2023)

Role of Adiponectin in Central Nervous System Disorders
por: Bloemer, Jenna, et al.
Publicado: (2018)

Gut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress
por: Govindarajulu, Manoj, et al.
Publicado: (2020)

Effects of prenatal synthetic cannabinoid exposure on the cerebellum of adolescent rat offspring
por: Pinky, Priyanka D., et al.
Publicado: (2021)

Adiponectin Knockout Mice Display Cognitive and Synaptic Deficits
por: Bloemer, Jenna, et al.
Publicado: (2019)

Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease
por: Ramesh, Sindhu, et al.
Publicado: (2018)

Drug Discovery and Development of Novel Therapeutics for Inhibiting TMAO in Models of Atherosclerosis and Diabetes
por: Steinke, Ian, et al.
Publicado: (2020)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

Neuronal CXCL10/CXCR3 Axis Mediates the Induction of Cerebral Hyperexcitability by Peripheral Viral Challenge
por: Petrisko, Tiffany J., et al.
Publicado: (2020)

SIRT3 activator Honokiol attenuates β-Amyloid by modulating amyloidogenic pathway
por: Ramesh, Sindhu, et al.
Publicado: (2018)

Prenatal Cannabinoid Exposure Elicits Memory Deficits Associated with Reduced PSA-NCAM Expression, Altered Glutamatergic Signaling, and Adaptations in Hippocampal Synaptic Plasticity
por: Pinky, Priyanka D., et al.
Publicado: (2023)

Doxorubicin induces dysregulation of AMPA receptor and impairs hippocampal synaptic plasticity leading to learning and memory deficits
por: Alhowail, Ahmad H., et al.
Publicado: (2021)

Commentary: Neutral Commentary on Frontiers Article “Cobalt Chloride Upregulates Impaired HIF-1α Expression to Restore Sevoflurane Post-conditioning-Dependent Myocardial Protection in Diabetic Rats”
por: Ghanei, Nila, et al.
Publicado: (2017)

Phenyl-2-aminoethyl selenide ameliorates hippocampal long-term potentiation and cognitive deficits following doxorubicin treatment
por: Alhowail, Ahmad H., et al.
Publicado: (2023)

Concurrent nicotine exposure to prenatal alcohol consumption alters the hippocampal and cortical neurotoxicity
por: Bhattacharya, Dwipayan, et al.
Publicado: (2020)

A Selective PPARγ Modulator Reduces Hepatic Fibrosis
por: McVicker, Benita L., et al.
Publicado: (2020)

Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator
por: Xie, Xinni, et al.
Publicado: (2017)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

Prostaglandins as PPARγ Modulators in Adipogenesis
por: Fujimori, Ko
Publicado: (2012)

Cross-Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity
por: Leonardini, Anna, et al.
Publicado: (2009)

Selective Modulators of PPAR-γ Activity: Molecular Aspects Related to Obesity and Side-Effects
por: Zhang, Fang, et al.
Publicado: (2007)

The Model of PPARγ-Downregulated Signaling in Psoriasis
por: Sobolev, Vladimir, et al.
Publicado: (2020)

Analysis of PPARγ Signaling Activity in Psoriasis
por: Sobolev, Vladimir, et al.
Publicado: (2021)

Therapeutic Advantages of Dual Targeting of PPAR-δ and PPAR-γ in an Experimental Model of Sporadic Alzheimer’s Disease
por: Reich, D, et al.
Publicado: (2018)

Dysregulation of the Amniotic PPARγ Pathway by Phthalates: Modulation of the Anti-Inflammatory Activity of PPARγ in Human Fetal Membranes
por: Antoine, Audrey, et al.
Publicado: (2022)

Ligand Modulated Antagonism of PPARγ by Genomic and Non-Genomic Actions of PPARδ
por: Gustafsson, Mattias C. U., et al.
Publicado: (2009)

PPAR-γ Modulators as Current and Potential Cancer Treatments
por: Chi, Tiange, et al.
Publicado: (2021)

Selective PPARγ modulator diosmin improves insulin sensitivity and promotes browning of white fat
por: Yu, Jian, et al.
Publicado: (2023)

Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis
por: Fang, Dongliang, et al.
Publicado: (2021)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Rosiglitazone activation of PPARγ suppresses fractalkine signaling
por: Wan, Yihong, et al.
Publicado: (2010)

PPAR-γ Signaling Crosstalk in Mesenchymal Stem Cells
por: Takada, Ichiro, et al.
Publicado: (2010)

Lysophospholipid-Related Diseases and PPARγ Signaling Pathway
por: Tsukahara, Tamotsu, et al.
Publicado: (2017)

The Interplay of WNT and PPARγ Signaling in Vascular Calcification
por: Reinhold, Stefan, et al.
Publicado: (2020)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

A structural mechanism for directing corepressor-selective inverse agonism of PPARγ
por: Brust, Richard, et al.
Publicado: (2018)

Magnolol dimer-derived fragments as PPARγ-selective probes
por: Dreier, Dominik, et al.
Publicado: (2018)

The Development of INT131 as a Selective PPARγ Modulator: Approach to a Safer Insulin Sensitizer
por: Higgins, Linda S., et al.
Publicado: (2008)

Selective modulator of nuclear receptor PPARγ with reduced adipogenic potential ameliorates experimental nephrotic syndrome
por: Bryant, Claire, et al.
Publicado: (2022)

Hippocampal Genetic Knockdown of PPARδ Causes Depression-Like Behaviors and Neurogenesis Suppression
por: Chen, Fang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rd4c8vo2qb2gm08elshi1khvgr